Journal article
Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
Abstract
OBJECTIVE: To compare the efficacy and cost-effectiveness of enoxaparin, a low-molecular-weight heparin derivative, with that of low-dose warfarin in the prevention of deep-vein thrombosis (DVT) after total hip replacement.
DATA SOURCES: English-language articles on enoxaparin and warfarin prophylaxis is patients undergoing total hip replacement published from January 1982 to December 1992.
Authors
O'Brien BJ; Anderson DR; Goeree R
Journal
Canadian Medical Association Journal, Vol. 150, No. 7, pp. 1083–1090
Publication Date
April 1, 1994
ISSN
0820-3946